We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
26
Nebius Group N.V.
NBIS
$38.3B
| $267M | 0.66% |
5,330,634
-338,224
| -6% | -$13.5M |
|
27
Alphabet (Google) Class A
GOOGL
$4.08T
| $255M | 0.63% |
3,591,380
-31,040
| -0.9% | -$2.09M |
|
28
ServiceNow
NOW
$119B
| $251M | 0.62% |
3,101,915
-144,480
| -4% | -$10.2M |
|
|
29
IBM
IBM
$214B
| $246M | 0.61% |
2,127,631
+2,108,344
| +10,931% | +$245M |
|
|
BZUN
30
Baozun
BZUN
$174M
| $245M | 0.61% |
6,376,060
-671,931
| -10% | -$21.1M |
|
31
Visa
V
$707B
| $241M | 0.6% |
1,246,917
-19,046
| -2% | -$3.48M |
|
32
DexCom
DXCM
$29.2B
| $238M | 0.59% |
2,343,380
-110,864
| -5% | -$9.92M |
|
33
PNC Financial Services
PNC
$99.6B
| $230M | 0.57% |
2,185,526
-82,271
| -4% | -$8.67M |
|
34
Amgen
AMGN
$211B
| $229M | 0.57% |
969,535
-46,524
| -5% | -$10.6M |
|
35
Moderna
MRNA
$21.7B
| $228M | 0.56% |
3,553,804
-1,129,783
| -24% | -$61.9M |
|
36
Wingstop
WING
$3.91B
| $211M | 0.52% |
1,516,938
+111,388
| +8% | +$13M |
|
37
CoStar Group
CSGP
$12B
| $192M | 0.47% |
2,695,150
+43,390
| +2% | +$2.81M |
|
38
lululemon athletica
LULU
$13.5B
| $184M | 0.46% |
589,420
-23,671
| -4% | -$6.05M |
|
39
Fidelity National Information Services
FIS
$23.8B
| $182M | 0.45% |
1,355,104
+1,889
| +0.1% | +$248K |
|
40
Salesforce
CRM
$154B
| $179M | 0.44% |
956,151
-29,607
| -3% | -$4.99M |
|
41
Credicorp
BAP
$30.5B
| $175M | 0.43% |
1,312,768
+228,176
| +21% | +$32.5M |
|
42
Mercury Systems
MRCY
$5.5B
| $174M | 0.43% |
2,217,350
-112,977
| -5% | -$9.25M |
|
|
43
KeyCorp
KEY
$24.1B
| $170M | 0.42% |
13,961,514
+6,962,569
| +99% | +$80.9M |
|
|
44
Gilead Sciences
GILD
$167B
| $170M | 0.42% |
2,205,694
-4,930,612
| -69% | -$378M |
|
45
Abbott
ABT
$191B
| $166M | 0.41% |
1,810,714
-213,100
| -11% | -$19.3M |
|
46
Zai Lab
ZLAB
$2.07B
| $163M | 0.4% |
1,988,989
| – | – |
|
47
Blackrock
BLK
$170B
| $163M | 0.4% |
299,604
-12,068
| -4% | -$6.09M |
|
|
SPLK
48
DELISTED
Splunk Inc
SPLK
| $158M | 0.39% |
794,066
-45,753
| -5% | -$7.24M |
|
49
Home Depot
HD
$340B
| $156M | 0.39% |
622,358
+71,621
| +13% | +$16.4M |
|
50
Sherwin-Williams
SHW
$84.9B
| $150M | 0.37% |
780,402
-31,167
| -4% | -$5.62M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.